Atara Biotherapeutics (ATRA) News Today $7.72 -0.24 (-3.02%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ATRA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period ATRA - Atara Biotherapeutics Inc Key Metrics - MorningstarJune 26, 2025 | morningstar.comMAtara Biotherapeutics, Inc. (ATRA) - Yahoo FinanceJune 26, 2025 | finance.yahoo.comMillennium Management LLC Has $135,000 Stock Position in Atara Biotherapeutics, Inc. (NASDAQ:ATRA)June 13, 2025 | marketbeat.comAtara Biotherapeutics, Inc. (NASDAQ:ATRA) Given Consensus Rating of "Moderate Buy" by AnalystsJune 6, 2025 | marketbeat.comRedmile Group, LLC's Strategic Acquisition in Atara Biotherapeutics IncMay 29, 2025 | gurufocus.comYanina Grant-Huerta Sells 2,218 Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) StockMay 21, 2025 | insidertrades.comAtara Biotherapeutics appoints Huang, Subramanian to board of directorsMay 18, 2025 | msn.comAtara Biotherapeutics sets stock and warrant offering pricesMay 16, 2025 | investing.comAtara Biotherapeutics Appoints James Huang and Nachi Subramanian to Board of DirectorsMay 16, 2025 | businesswire.comAtara Biotherapeutics Announces Pricing of $16 Million OfferingMay 15, 2025 | finance.yahoo.comAtara Biotherapeutics Announces First Quarter Financial Results and Operational ProgressMay 15, 2025 | businesswire.comAtara Biotherapeutics Says FDA Lifts Clinical HoldMay 5, 2025 | marketwatch.comAtara Biotherapeutics Provides Regulatory Updates on EBVALLO™ (tabelecleucel)May 5, 2025 | finance.yahoo.comAtara Biotherapeutics (ATRA) Receives a Buy from TD CowenMarch 10, 2025 | markets.businessinsider.comAtara Biotherapeutics Faces Potential Liquidation: Strategic Decisions Crucial for Investor OutcomesMarch 9, 2025 | tipranks.comAtara Biotherapeutics to Cut Half of Workforce Amid RestructuringMarch 7, 2025 | marketwatch.comAtara Biotherapeutics reports Q4 EPS ($1.19) vs. ($14.00) last yearMarch 7, 2025 | markets.businessinsider.comAtara Biotherapeutics Reports 2024 Financial ResultsMarch 7, 2025 | tipranks.comAtara Biotherapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Operational ProgressMarch 7, 2025 | businesswire.comAnhco Nguyen Sells 3,331 Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) StockMarch 6, 2025 | insidertrades.comWolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Atara Biotherapeutics, Inc. for potential violations of securities lawsFebruary 14, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRAFebruary 11, 2025 | prnewswire.comAtara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)February 7, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRAFebruary 4, 2025 | prnewswire.comWolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Atara Biotherapeutics, Inc. for potential violations of securities lawsFebruary 3, 2025 | globenewswire.comAtara Biotherapeutics, Inc. (NASDAQ:ATRA) Given Consensus Recommendation of "Moderate Buy" by AnalystsFebruary 1, 2025 | marketbeat.comWolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Atara Biotherapeutics, Inc. for potential violations of securities lawsJanuary 30, 2025 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRAJanuary 28, 2025 | prnewswire.comAtara stock holds Neutral rating after workforce cutJanuary 28, 2025 | msn.comATRA Investors Have Opportunity to Join Atara Biotherapeutics, Inc. Securities Fraud Investigation with the Schall Law FirmJanuary 28, 2025 | prnewswire.comAtara reduction in workforce to impact 50% of current employeesJanuary 27, 2025 | msn.comAtara to cut 50% of workforce amid FDA woesJanuary 27, 2025 | msn.comATRA Investors Have Opportunity to Join Atara Biotherapeutics, Inc. Securities Fraud Investigation with the Schall Law FirmJanuary 27, 2025 | businesswire.comAtara Biotherapeutics Faces Strategic Uncertainty Amid FDA Hold and CRL IssuesJanuary 22, 2025 | markets.businessinsider.comAtara Biotherapeutics price target lowered to $5 from $10 at StifelJanuary 22, 2025 | markets.businessinsider.comStifel cuts Atara Biotherapeutics target to $5, holds ratingJanuary 21, 2025 | msn.comAtara Biotherapeutics Faces Uncertainty Amid FDA Clinical Hold and Financing Needs, Resulting in Hold RatingJanuary 21, 2025 | markets.businessinsider.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRAJanuary 21, 2025 | prnewswire.comUS FDA puts clinical hold on Atara's trials for cancer cell therapiesJanuary 21, 2025 | reuters.comAtara extends losses after FDA clinical holdJanuary 21, 2025 | msn.comAtara Biotherapeutics price target lowered to $17 from $21 at CanaccordJanuary 18, 2025 | markets.businessinsider.comBuy Rating for Atara Biotherapeutics Driven by Manufacturing Resolution and Strategic InitiativesJanuary 18, 2025 | markets.businessinsider.comAtara Bio reiterated at Buy by Canaccord on expected Ebvallo manufactureJanuary 17, 2025 | msn.comAtara Shares Sink After FDA Stalls Cancer TreatmentJanuary 16, 2025 | marketwatch.comAtara Biotherapeutics Shares Plunge 38% Following FDA Response to EBVALLO ApplicationJanuary 16, 2025 | sg.finance.yahoo.comAtara announces Ebvallo CRL did not find clinical efficacy deficienciesJanuary 16, 2025 | markets.businessinsider.comAtara Biotherapeutics trading halted, news pendingJanuary 16, 2025 | markets.businessinsider.comAtara stock plummets on FDA setback for EBV drugJanuary 16, 2025 | in.investing.comFDA Rejects Atara's Request to Bring Blood Cancer Treatment to MarketJanuary 16, 2025 | marketwatch.comAtara Biotherapeutics Provides Regulatory and Business Update on EBVALLOTM (tabelecleucel)January 16, 2025 | stockhouse.com Get Atara Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRA and its competitors with MarketBeat's FREE daily newsletter. Email Address ATRA Media Mentions By Week ATRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATRA News Sentiment▼0.630.90▲Average Medical News Sentiment ATRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATRA Articles This Week▼31▲ATRA Articles Average Week Get Atara Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACIU News TLSA News CTOR News PROK News EDIT News FDMT News CTMX News OGI News VTYX News SLS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATRA) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atara Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atara Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
